|
|
|
LECTURES
& BREAKOUTS
Tuesday,
February 1, 2000
|
|
Time
|
Title |
Speaker |
|
 |
|
8:00-8:10
|
Welcome
and Introduction |
Richard
Larson,
MD |
|
|
|
8:10-8:30
|
Molecular
Paradigims/Mechanisms in Acute Myeloid Leukemia |
Gary
Gilliland, MD, PhD |
|
|
| 8:50-9:10 |
Signal
Transduction Abnormalities in Leukemia |
Jerald
Radich, MD
|
|
|
| 9:10-9:30 |
Update
on Apoptosis |
Scott
Kaufmann, MD, PhD |
|
|
|
9:45-10:05 |
Classic
and Alternative Drug Resistance Pathways: ABC Transporters |
Alan
List, MD |
|
|
|
10:05-10:25 |
Antibody-Delivered Therapy |
Irwin
D. Bernstein, MD |
|
|
|
10:25-10:45 |
Immunotherapy |
Stanley
Riddell, MD |
|
|
|
10:45-11:05 |
New Agents and Strategies |
Elihu
Estey, MD |
|
|
| 11:05-11:30
|
General
Discussion: Questions and Answers
|
|
| |
|
Wednesday,
February 2, 2000
|
|
Time
|
Title |
Speaker |
|
|
|
|
10:00-12:00 |
Report from Working Group A |
Charles A. Schiffer,
MD
|
|
|
| |
Report
from Working Group B |
Frederick
R. Appelbaum, MD |
|
|
| |
Report
from Working Group C |
Martin S. Tallman,
MD
|
|
|
| |
Report
from Working Group D |
Michael
A. Caligiuri, MD |
|
|
| |
General
Discussion: Questions and Answers |
|
|
|
| 12:00
p.m. |
Adjourn |
|
|
